Arun Chandrasekharan

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 337 citations

Medicine, Oncology, Radiation Oncology +14

Impact of COVID-19 on cancer care in India: a cohort study

Priya Ranganathan, Manju Sengar, Girish Chinnaswamy et al. · The Lancet Oncology · 2021 · 164 citations · Full text

Medicine, Health Sciences, Oncology +14

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Cancer · 2019 · 130 citations

Medicine, Oncology, Radiation Oncology +11

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 102 citations · Full text

Medicine, Oncology, Chemotherapy +11

“Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia”

Jyoti Bajpai, S. Kagwade, Arun Chandrasekharan et al. · The Breast · 2019 · 56 citations · Full text

Medicine, Dermatology, Oncology +14